23.76

2.46% 0.57

After Hours: 24.10 0.34 +1.43%

Anbio Biotechnology (NNNN)

Overview News Price History Discussions Forecast

Anbio Biotechnology stock is traded at $23.76, with a volume of 16,969. It is up +2.46% in the last 24 hours and down -8.47% over the past month. Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Previous Close:

$23.19

Open:

$23.96

24h Volume:

16,969

Relative Volume:

0.30

Market Cap:

$1.04B

Revenue:

$7.54M

Net Income/Loss:

$2.82M

P/E Ratio:

375.95

EPS:

0.0632

Net Cash Flow:

$2.25M

1W Performance:

+13.47%

1M Performance:

-8.47%

6M Performance:

-33.67%

1Y Performance:

+221.08%

1-Day Range:

$22.18

$24.98

1-Week Range:

$20.64

$24.98

52-Week Range:

$5.89

$55.65

Anbio Biotechnology Stock (NNNN) Company Profile

Name

Anbio Biotechnology

Sector

Healthcare (1114)

Industry

Medical Instruments & Supplies (58)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NNNN's Discussions on Twitter

Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NNNN Anbio Biotechnology	23.76	1.02B	7.54M	2.82M	2.25M	0.0632
ISRG Intuitive Surgical Inc	469.98	167.61B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	158.27	44.35B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.26	36.19B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	42.67	34.11B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	226.31	33.24B	5.40B	1.49B	1.78B	10.12

Anbio Biotechnology Stock (NNNN) Latest News

Mar 19, 2026

Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat

Mar 19, 2026

Mar 17, 2026

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com

Mar 17, 2026

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times

Mar 17, 2026

Anbio CEO to outline rapid diagnostic plans at KeyBanc investor event - Stock Titan

Mar 17, 2026

Mar 14, 2026

Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 14, 2026

Mar 09, 2026

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World

Mar 09, 2026

Mar 08, 2026

Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today

Mar 08, 2026

Mar 07, 2026

Anbio Biotechnology falls -5.8% - MSN

Mar 07, 2026

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 07, 2026

Mar 06, 2026

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 06, 2026

Mar 04, 2026

Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge

Mar 04, 2026

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 04, 2026

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World

Mar 04, 2026

TechTarget (TTGT) to Release Earnings on Wednesday - Defense World

Mar 04, 2026

Mar 03, 2026

Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha

Mar 03, 2026

NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Anbio Biotechnology Prioritizes Profitability Over Sales Volume - National Today

Mar 03, 2026

Mar 01, 2026

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World

Mar 01, 2026

Feb 28, 2026

NNNN Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Anbio Biotechnology Outperforms Oncocyte in Financial Metrics - National Today

Feb 27, 2026

Feb 26, 2026